CIBC Bancorp USA’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
Other funds holding RPRX
CIBC Bancorp USA's RPRX Position: Q3 2026 in Review
CIBC Bancorp USA increased its Royalty Pharma (RPRX) stake by 2.6% in Q3 2026, buying an estimated $28.4K and bringing the position to 19,048 shares worth $1.11M. The position accounts for ﹤0.01% of the portfolio, ranked #1082.
CIBC Bancorp USA first reported a position in RPRX in Q3 2025 and has held it in 4 quarters since. 704 funds tracked by Wall St. Rank hold RPRX as of Q3 2026.
- CIBC Bancorp USA held 19,048 shares of Royalty Pharma worth $1.11M as of Q3 2026.
- CIBC Bancorp USA bought 482 Royalty Pharma shares in Q3 2026, an estimated $28.4K.
- Royalty Pharma made up ﹤0.01% of CIBC Bancorp USA's portfolio in Q3 2026, its #1082 holding.
- CIBC Bancorp USA first reported a position in Royalty Pharma in Q3 2025 and has held it in 4 quarters since.
- 704 funds tracked by Wall St. Rank held Royalty Pharma as of Q3 2026.
Based on CIBC Bancorp USA's 13F filing for Q3 2026, filed 13 Nov 2026.